Table 2. All adverse events with relationship of possible, or probable, or definite to iniparib (No. of pts had the type of AE >=5).

Adverse Event	mTMZ N=23 No. (% of pts)	cTMZ N=20 No. (% of pts)	Total N=43 No. (% of pts)
ALT		6 (30)	6 (14)
Anemia	13 (57)	11 (55)	24 (56)
Constipation	9 (39)	7 (35)	16 (37)
Dizziness	5 (22)		5 (12)
Fatigue	15 (65)	13 (65)	28 (65)
Nausea	9 (39)	9 (45)	18 (42)
Rash maculo-papular	5 (22)		5 (12)
Platelet decreased	15 (65)	6 (30)	21 (49)
White blood cell count decreased	11 (48)	17 (85)	28 (65)